|
1
|
Gligorov J and Lotz JP: Preclinical
pharmacology of the taxanes: Implications of the differences.
Oncologist. 9 (Suppl 2):3–8. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guastalla JP, Lhommé C, Dauplat J, Namer
M, Bonneterre J, Oberling F, Pouillart P, Fumoleau P, Kerbrat P,
Tubiana N, et al: Taxol (paclitaxel) safety in patients with
platinum pretreated ovarian carcinoma: An interim analysis of a
phase II multicenter study. Ann Oncol. 5 (Suppl 6):S33–S38.
1994.PubMed/NCBI
|
|
3
|
Ohtsu T, Sasaki Y, Tamura T, Miyata Y,
Nakanomyo H, Nishiwaki Y and Saijo N: Clinical pharmacokinetics and
pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour
infusion. Clin Cancer Res. 1:599–606. 1995.PubMed/NCBI
|
|
4
|
Newman DJ, Cragg GM and Snader KM: Natural
products as sources of new drugs over the period 1981–2002. J Nat
Prod. 66:1022–1037. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sylvester PW, Kaddoumi A, Nazzal S and El
Sayed KA: The value of tocotrienols in the prevention and treatment
of cancer. J Am Coll Nutr. 29 (Suppl):324S–333S. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YJ: Potential role of tetrandrine in
cancer therapy. Acta Pharmacol Sin. 23:1102–1106. 2002.PubMed/NCBI
|
|
7
|
Farina HG, Pomies M, Alonso DF and Gomez
DE: Antitumor and antiangiogenic activity of soy isoflavone
genistein in mouse models of melanoma and breast cancer. Oncol Rep.
16:885–891. 2006.PubMed/NCBI
|
|
8
|
Rafieian-Kopaei M and Movahedi M: Breast
cancer chemopreventive and chemotherapeutic effects of Camellia
Sinensis (green tea): An updated review. Electron Physician.
9:3838–3844. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Badr El-Din NK, Noaman E and Ghoneum M: In
vivo tumor inhibitory effects of nutritional rice bran supplement
MGN-3/Biobran on Ehrlich carcinoma-bearing mice. Nutr Cancer.
60:235–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Badr El-Din NK, Abdel Fattah SM, Pan D,
Tolentino L and Ghoneum M: Chemopreventive activity of
MGN-3/Biobran against chemical induction of glandular stomach
carcinogenesis in rats and its apoptotic effect in gastric cancer
cells. Integr Cancer Ther. 15:NP26–NP34. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pérez-Martínez A, Valentín J, Fernández L,
Hernández-Jiménez E, López-Collazo E, Zerbes P, Schwörer E, Nuñéz
F, Martín IG, Sallis H, et al: Arabinoxylan rice bran
(MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity
against neuroblastoma in vitro and in vivo. Cytotherapy.
17:601–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ghoneum M and Gollapudi S: Susceptibility
of the human LNCaP prostate cancer cells to the apoptotic effect of
marina crystal minerals (MCM) in vitro. Oncol Rep. 22:155–159.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghoneum M, Seto Y, Sato S, Ghoneum A,
Braga M and Gollapudi S: Gross thymic extract, Thymax, induces
apoptosis in human breast cancer cells in vitro through the
mitochondrial pathway. Anticancer Res 28 (3A). 1603–1609. 2008.
|
|
14
|
Ghoneum M and Gimzewski J: Apoptotic
effect of a novel kefir product, PFT, on multidrug-resistant
myeloid leukemia cells via a hole-piercing mechanism. Int J Oncol.
44:830–837. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gollapudi S and Ghoneum M: MGN-3/Biobran,
modified arabinoxylan from rice bran, sensitizes human breast
cancer cells to chemotherapeutic agent, daunorubicin. Cancer Detect
Prev. 32:1–6. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghoneum M: Wheat and rice in disease
prevention and health. In: Apoptosis and Arabinoxylan Rice Bran.
Watson RR, Preedy V and Zibadi S: Elsevier Science & Technology
Book; pp. 399–404. 2014
|
|
17
|
Endo Y and Kanbayashi H: Modified rice
bran beneficial for weight loss of mice as a major and acute
adverse effect of Cisplatin. Pharmacol Toxicol. 92:300–303. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jacoby HI, Wnorowski G, Sakata K and Maeda
H: The effect of MGN-3 on cisplatin and doxorubicin induced
toxicity in the rat. J. Nutraceuticals Funct Med Foods. 3:3–11.
2001. View Article : Google Scholar
|
|
19
|
Bang MH, Van Riep T, Thinh NT, Song H,
Dung TT, Van Truong L, Van Don L, Ky TD, Pan D, Shaheen M, et al:
Arabinoxylan rice bran (MGN-3) enhances the effects of
interventional therapies for the treatment of hepatocellular
carcinoma: A three-year randomized clinical trial. Anticancer Res.
30:5145–5151. 2010.PubMed/NCBI
|
|
20
|
Goel A and Aggarwal BB: Curcumin, the
golden spice from Indian saffron, is a chemosensitizer and
radiosensitizer for tumors and chemoprotector and radioprotector
for normal organs. Nutr Cancer. 62:919–930. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Limtrakul P: Curcumin as chemosensitizer.
Adv Exp Med Biol. 595:269–300. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rege BD, Kao JP and Polli JE: Effects of
nonionic surfactants on membrane transporters in Caco-2 cell
monolayers. Eur J Pharm Sci. 16:237–246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tian H and Pan QC: A comparative study on
effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on
reversal of multidrug resistance. Yao Xue Xue Bao. 32:245–250.
1997.(In Chinese). PubMed/NCBI
|
|
24
|
Choi SU, Park SH, Kim KH, Choi EJ, Kim S,
Park WK, Zhang YH, Kim HS, Jung NP and Lee CO: The
bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline,
enhance the cytotoxicity of multidrug resistance-related drugs via
modulation of P-glycoprotein. Anticancer Drugs. 9:255–261. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen C, Zhou J and Ji C: Quercetin: A
potential drug to reverse multidrug resistance. Life Sci.
87:333–338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ghoneum M and Gollapudi S: Induction of
apoptosis in breast cancer cells by Saccharomyces
cerevisiae, the bakers yeast, in vitro. Anticancer Res 24 (3a).
1455–1463. 2004.
|
|
27
|
Ghoneum M and Gollapudi S: Modified
arabinoxylan rice bran (MGN-3/Biobran) enhances yeast-induced
apoptosis in human breast cancer cells in vitro. Anticancer Res 25
(2A). 859–870. 2005.
|
|
28
|
Ghoneum M and Gollapudi S: Synergistic
role of arabinoxylan rice bran (MGN-3/Biobran) in S.
cerevisiae-induced apoptosis of monolayer breast cancer MCF-7
cells. Anticancer Res 25 (6B). 4187–4196. 2005.
|
|
29
|
Ghoneum M, Hamilton J, Brown J and
Gollapudi S: Human squamous cell carcinoma of the tongue and colon
undergoes apoptosis upon phagocytosis of Saccharomyces
cerevisiae, the bakers yeast, in vitro. Anticancer Res 25 (2A).
981–989. 2005.
|
|
30
|
Ghoneum M, Brown J and Gollapudi S: ‘Yeast
therapy for the treatment of cancer and its enhancement by
MGN-3/Biobran, an arabinoxylan rice bran’ in apoptosis review. Nova
Science Publishers Inc.; Hauppague, NY: pp. 185–200. 2007
|
|
31
|
Ghoneum M, Wang L, Agrawal S and Gollapudi
S: Yeast therapy for the treatment of breast cancer: A nude mice
model study. In Vivo. 21:251–258. 2007.PubMed/NCBI
|
|
32
|
Ghoneum M, Badr El-Din NK, Noaman E and
Tolentino L: Saccharomyces cerevisiae, the Bakers Yeast, suppresses
the growth of Ehrlich carcinoma-bearing mice. Cancer Immunol
Immunother. 57:581–592. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yarkoni E, Lederer E and Rapp HJ:
Immunotherapy of experimental cancer with a mixture of synthetic
muramyl dipeptide and trehalose dimycolate. Infect Immun.
32:273–276. 1981.PubMed/NCBI
|
|
34
|
Badr El-Din NK, Mahmoud AZ, Hassan TA and
Ghoneum M: Bakers yeast sensitizes metastatic breast cancer cells
to paclitaxel in vitro. Integr Cancer Ther. 17:542–550. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Calixto-Campos C, Zarpelon AC, Corrêa M,
Cardoso RD, Pinho-Ribeiro FA, Cecchini R, Moreira EG, Crespigio J,
Bernardy CC, Casagrande R, et al: The Ehrlich tumor induces
pain-like behavior in mice: A novel model of cancer pain for
pathophysiological studies and pharmacological screening. BioMed
Res Int. 2013:6248152013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ehrlich and Apolant. Beobachtungen Über
Maligne Mausentumoren, . Berlin: Klin Wochenschr; 28. pp. 871–874.
1905, (In German).
|
|
37
|
Kaleoğlu Ö and İşli N: Ehrlich -Lettre
Asit Tümörü. Tip Fak Mecm. 40:978–984. 1977.(In Turkish).
|
|
38
|
Mishra S, Tamta AK, Sarikhani M, Desingu
PA, Kizkekra SM, Pandit AS, Kumar S, Khan D, Raghavan SC and
Sundaresan NR: Subcutaneous Ehrlich ascites carcinoma mice model
for studying cancer-induced cardiomyopathy. Sci Rep. 8:55992018.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cattoretti G, Becker MH, Key G, Duchrow M,
Schlüter C, Galle J and Gerdes J: Monoclonal antibodies against
recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect
proliferating cells in microwave-processed formalin-fixed paraffin
sections. J Pathol. 168:357–363. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Reynolds ES: The use of lead citrate at
high pH as an electron microscopy. J Cell Biol. 17:208–212. 1963.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Marupudi NI, Han JE, Li KW, Renard VM,
Tyler BM and Brem H: Paclitaxel: A review of adverse toxicities and
novel delivery strategies. Expert Opin Drug Saf. 6:609–621. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gustafson DL, Long ME, Zirrolli JA, Duncan
MW, Holden SN, Pierson AS and Eckhardt SG: Analysis of docetaxel
pharmacokinetics in humans with the inclusion of later sampling
time-points afforded by the use of a sensitive tandem LCMS assay.
Cancer Chemother Pharmacol. 52:159–166. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xu G, Pan J, Martin C and Yeung S-CJ:
Angiogenesis inhibition in the in vivo antineoplastic effect of
manumycin and paclitaxel against anaplastic thyroid carcinoma. J
Clin Endocrinol Metab. 86:1769–1777. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Stassi G, Todaro M, Zerilli M,
Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di
Gesù G and De Maria R: Thyroid cancer resistance to
chemotherapeutic drugs via autocrine production of interleukin-4
and interleukin-10. Cancer Res. 63:6784–6790. 2003.PubMed/NCBI
|
|
45
|
Piñeiro D, Martín ME, Guerra N, Salinas M
and González VM: Calpain inhibition stimulates caspase-dependent
apoptosis induced by taxol in NIH3T3 cells. Exp Cell Res.
313:369–379. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Potemski P and Płuzańska A:
Pharmacological action of paclitaxel. Pol Merkur Lekarski. 6:27–29.
1999.(In Polish). PubMed/NCBI
|
|
47
|
Badr El-Din NK, Ali DA, Alaa El-Dein M and
Ghoneum M: Enhancing the apoptotic effect of a low dose of
paclitaxel on tumor cells in mice by arabinoxylan rice bran
(MGN-3/Biobran). Nutr Cancer. 68:1010–1020. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ghoneum M, Matsuura M, Braga M and
Gollapudi S: S. cerevisiae induces apoptosis in human
metastatic breast cancer cells by altering intracellular
Ca2+ and the ratio of Bax and Bcl-2. Int J Oncol.
33:533–539. 2008.PubMed/NCBI
|
|
49
|
Jordan MA and Wilson L: The use and action
of drugs in analyzing mitosis. Methods Cell Biol. 61:267–295. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Morse DL, Gray H, Payne CM and Gillies RJ:
Docetaxel induces cell death through mitotic catastrophe in human
breast cancer cells. Mol Cancer Ther. 4:1495–1504. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ghoneum M, Badr El-Din NK, Ali DA and
El-Dein MA: Modified arabinoxylan from rice bran, MGN-3/biobran,
sensitizes metastatic breast cancer cells to paclitaxel in vitro.
Anticancer Res. 34:81–87. 2014.PubMed/NCBI
|
|
52
|
Yu XJ, Sun K, Tang XH, Zhou CJ, Sun H, Yan
Z, Fang L, Wu HW, Xie YK and Gu B: Harmine combined with paclitaxel
inhibits tumor proliferation and induces apoptosis through
down-regulation of cyclooxygenase-2 expression in gastric cancer.
Oncol Lett. 12:983–988. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Gonçalves A, Braguer D, Carles G, André N,
Prevôt C and Briand C: Caspase-8 activation independent of
CD95/CD95-L interaction during paclitaxel-induced apoptosis in
human colon cancer cells (HT29-D4). Biochem Pharmacol.
60:1579–1584. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Peng ZG, Liu DC, Yao YB, Feng XL, Huang X,
Tang YL, Yang J and Wang XX: Paclitaxel induces apoptosis in
leukemia cells through a JNK activation-dependent pathway. Genet
Mol Res. 15:150139042016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Varbiro G, Veres B, Gallyas F Jr and
Sumegi B: Direct effect of Taxol on free radical formation and
mitochondrial permeability transition. Free Radic Biol Med.
31:548–558. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Roy M and Mukherjee S: Reversal of
resistance towards cisplatin by curcumin in cervical cancer cells.
Asian Pac J Cancer Prev. 15:1403–1410. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Abulrob AN, Mason M, Bryce R and Gumbleton
M: The effect of fatty acids and analogues upon intracellular
levels of doxorubicin in cells displaying P-glycoprotein mediated
multidrug resistance. J Drug Target. 8:247–256. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Gelsomino G, Corsetto PA, Campia I,
Montorfano G, Kopecka J, Castella B, Gazzano E, Ghigo D, Rizzo AM
and Riganti C: Omega 3 fatty acids chemosensitize multidrug
resistant colon cancer cells by down-regulating cholesterol
synthesis and altering detergent resistant membranes composition.
Mol Cancer. 12:1372013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Elwakkad A, Ghoneum M, El-sawi M, Mohamed
SI, Gamal el Din AA, Pan D and Elqattan GM: Bakers yeast induces
apoptotic effects and histopathological changes on skin tumors in
mice. Cogent Med. 5:14376732018. View Article : Google Scholar
|
|
60
|
Fahrig R: Development of host-mediated
mutagenicity tests-yeast systems. II. Recovery of yeast cells out
of testes, liver, lung, and peritoneum of rats. Mutat Res.
31:381–394. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Frezza D, Zeiger E and Gupta BN: The
intrasanguineous host-mediated assay procedure distribution and
retention of yeast in the mouse. Mutat Res. 64:295–305. 1979.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Maejima K, Shimoda K, Morita C, Fujiwara T
and Kitamura T: Colonization and pathogenicity of Saccharomyces
cerevisiae, MC16, in mice and cynomolgus monkeys after oral and
intravenous administration. Jpn J Med Sci Biol. 33:271–276. 1980.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Babineau TJ, Marcello P, Swails W, Kenler
A, Bistrian B and Forse RA: Randomized phase I/II trial of a
macrophage-specific immunomodulator (PGG-glucan) in high-risk
surgical patients. Ann Surg. 220:601–609. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Babineau TJ, Hackford A, Kenler A,
Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P
and Benotti P: A phase II multicenter, double-blind, randomized,
placebo-controlled study of three dosages of an immunomodulator
(PGG-glucan) in high-risk surgical patients. Arch Surg.
129:1204–1210. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wanke B and Londero AT: Epidemiology and
paracoccidioidomycosis infection. Paracoccidioidomycosis. Franco M,
Lacaz CS, Restrepo-Moreno A and Del Negro G: CRC Press; Boca Raton:
pp. 109–120. 1994
|
|
66
|
Meira DA, Pereira PC, Marcondes-Machado J,
Mendes RP, Barraviera B, Pellegrino Júnior J, Rezkallah-Iwasso MT,
Peracoli MT, Castilho LM, Thomazini I, et al: The use of glucan as
immunostimulant in the treatment of paracoccidioidomycosis. Am J
Trop Med Hyg. 55:496–503. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Costa G and Holland JF: Effects of Krebs-2
carcinoma on the lipide metabolism of male Swiss mice. Cancer Res.
22:1081–1083. 1962.PubMed/NCBI
|
